Trial Profile
Biomarkers in tumor microenvironment correlating with clinical responses to intratumorally injected TLR4 agonist G100
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2017
Price :
$35
*
At a glance
- Drugs Glycopyranosyl lipid adjuvant (Primary)
- Indications Merkel cell carcinoma
- Focus Biomarker; Pharmacodynamics
- 28 Nov 2017 New trial record